Lupus Therapeutics

Al Roy, Executive Director of Lupus Research Alliance affiliate Lupus Therapeutics, speaks to the importance of diversity in lupus clinical trials. Without diversity in clinical trials drug efficacy cannot be assured for all and treatment options will be limited for many lupus patients.

Sign up for our Newsletter

Use this tool to search all lupus trials and create a personalized list of studies by the type of lupus you have and where you live.

Sign up